Baxter’s Alliston manufacturing plant supplies the majority of IV and dialysis products to the Canadian health care system. In response to COVID-19, the company transitioned to a 24/7 production schedule to supply about 130 per cent capacity, seeking to supply as many IV bags as possible.
BD (Becton, Dickinson and Company) is committed to supporting health care systems across Canada in response to the COVID-19 pandemic by supplying critical technologies, such as diagnostic tools and injection devices.
In collaboration with the federal government, BD has recently received a large pandemic order to produce 37.6 million vaccine injection devices to support Canada in planning for a COVID-19 vaccination campaign.
The organization has also collaborated with Quebec Public Health and the provincial Ministry of Health to source a loaner testing unit to expedite COVID-19 testing in Quebec. With the fully integrated, BD MAX™ diagnostic testing system now on-site, clinicians at the Gatineau Public Health Labs can process patient swabs and diagnose cases of COVID-19 locally, within 2–3 hours of taking the sample. The lab previously had a capability of 50 tests per week, which has now increased to 1,400 per week.
